October 2024

TATA MOTORS Q2 JLR BIZ UPDATERetail sales in Q2 FY25 were 103,108 units, down 3% vs Q2 FY24Production in Q2 FY25 was restricted to c. 86,000 units, down 7% compared to c. 93,000units in Q2 FY24, as a result of aluminium supply disruptions reported in Q1 FY25. Wholesales in Q2 FY25 were 87,303 units, down 10% vs Q2 FY24Production and wholesale volumes are expected to recover strongly in the second half of the year i #FinancialNews #Financial MarketTrends TATA MOTORS Q2 JLR BIZ UPDATERetail sales in Q2 FY25 were 103,108 units, down 3% vs Q2 FY24Production in Q2 FY25 was restricted to c. 86,000 units, down 7% compared to c. 93,000units in Q2 FY24, as a result of aluminium supply disruptions reported in Q1 FY25. Wholesales in Q2 FY25 were 87,303 units, down 10% vs Q2 FY24Production and wholesale volumes are expected to recover strongly in the second half of the year i #FinancialNews #Financial MarketTrends

TATA MOTORS Q2 JLR BIZ UPDATE Retail sales in Q2 FY25 were 103,108 units, down...

COMMODITY OPTION TRADE BUY MCX CRUDEOIL OCT 6200 CE AT 250 TP 290 SL 225 (CMP-250) BUY MCX CRUDEOIL OCT 6200 CE AT 250 TP 290 SL 225 (CMP-250) #FinancialNews #Financial MarketTrends   https://earnfree.in/latest COMMODITY OPTION TRADE BUY MCX CRUDEOIL OCT 6200 CE AT 250 TP 290 SL 225 (CMP-250) BUY MCX CRUDEOIL OCT 6200 CE AT 250 TP 290 SL 225 (CMP-250) #FinancialNews #Financial MarketTrends   https://ift.tt/jmZBx8V

COMMODITY OPTION TRADE BUY MCX CRUDEOIL OCT 6200 CE AT 250 TP 290 SL 225...

. Opening Bell: Nifty: 25,088 (+0.34%) Sensex: 81,990.01(+0.35%) Banknifty: 51,610.25 (+0.27%) Top Gainer: TECHNOE, 1,623 (+6.00%) Top Loser: JUBLPHARMA, 1,064(-3.82%) #FinancialNews   https://earnfree.in/latest . Opening Bell: Nifty: 25,088 (+0.34%) Sensex: 81,990.01(+0.35%) Banknifty: 51,610.25 (+0.27%) Top Gainer: TECHNOE, 1,623 (+6.00%) Top Loser: JUBLPHARMA, 1,064(-3.82%) #FinancialNews   https://ift.tt/jmZBx8V

. Opening Bell:Nifty: 25,088 (+0.34%)Sensex: 81,990.01(+0.35%)Banknifty: 51,610.25 (+0.27%)Top Gainer: TECHNOE, 1,623 (+6.00%)Top Loser: JUBLPHARMA, 1,064(-3.82%)...

NATCO PHARMA: CO ANNOUNCES THAT MYLAN PHARMA INC. AND NOVO NORDISK HAVE REACHED A SETTLEMENT OF THE U.S. PATENT LITIGATION RELATED TO GENERIC OZEMPIC (SEMAGLUTIDE). #FinancialNews #Financial MarketTrends   https://earnfree.in/latest NATCO PHARMA: CO ANNOUNCES THAT MYLAN PHARMA INC. AND NOVO NORDISK HAVE REACHED A SETTLEMENT OF THE U.S. PATENT LITIGATION RELATED TO GENERIC OZEMPIC (SEMAGLUTIDE). #FinancialNews #Financial MarketTrends   https://ift.tt/jmZBx8V

NATCO PHARMA: CO ANNOUNCES THAT MYLAN PHARMA INC. AND NOVO NORDISK HAVE REACHED A SETTLEMENT...